Evidence map›Paper›PMID 41929869›Full record

ReviewJournal of anesthesia and translational medicine2024

Directions for analgesic development.

Ting Ge, Zhou Wu, Sha Sha, Xin Yang, He Liu, Lingzhen Song, Hongxing Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of anesthesia and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. CXCL13/CXCR5: a new target for pain treatment.International journal of surgery (London, England) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ting GeJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.
Zhou WuJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.
Sha ShaJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.
Xin YangJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.
He LiuDepartment of Anesthesiology, Huzhou Central Hospital, Huzhou 313000, China.
Lingzhen SongJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.
Hongxing ZhangJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiological pain represents a protective response to avoid further injury and is helpful for survival. However, pathological pain is a common disease/symptom significantly affecting the quality of daily life in affected patients. Great progress has been made recently in understanding of pain mechanisms and the development of analgesic drugs, yet analgesic development requires continuous innovation. This review aims to summarize potential directions for future analgesic development and to provide guidance for related mechanism studies.

Indexed as

AnalgesiaComorbidityNon-opioid analgesiaPainPain resilienceTraditional Chinese medicine

Identifiers

PMID41929869
PMCPMC13001732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.